Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Thymidine analogue excision and discrimination modulated by mutational complexes including single amino acid deletions of Asp-67 or Thr-69 in HIV-1 reverse transcriptase.
Optimal antiviral switching to minimize resistance risk in HIV therapy.
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
Definition of the viral targets of protective HIV-1-specific T cell responses.
Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates.
Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains.
HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse?
Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure.
Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.